GS-4571
AssetSmall molecule
GLP-1 receptor agonist
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Insulin/IGF-1 signalling
- Indications
- 0
- Trials
- 1
- Developers
- 1
Indications
1No named disease
Phase 1RECRUITINGNCT06562907clinicaltrials.gov7 Oct 2026
- Targets and what it contains2
- Owner and partners1
- Trials1
- Evidence for its targets2
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 1 source